2025-12-16
In Vitro Diagnostics (IVD) Market Size Forecast to Surge to USD 135.76 Billion by 2035 Driven by Point-of-Care and AI Innovations
Ottawa, Dec. 16, 2025 (GLOBE NEWSWIRE) -- The global in vitro diagnostics (IVD) market size is valued at USD 104.01 billion in 2025, and it is projected to expand from USD 106.16 billion in 2026 to approximately USD 135.76 billion by 2035 with a compound annual growth rate (CAGR) of 2.7% between 2026 and 2035. Key drivers include demand for faster, more accurate tests for cancer, diabetes, and infections, with strong growth in North America and Asia-Pacific.The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report@ https://www.precedenceresearch.com/sample/1130In Vitro Diagnostics Market Highlights:Regional Insight:North America dominated the market with a 42% revenue share in 2025.The Asia Pacific is expected to grow at a healthy CAGR during the forecast period.Product Trends:Reagents held a significant share in 2025.Instruments are expected to witness considerable growth during the forecast period.Test Location Trends:Point-of-Care testing led the market in 2025.Home Care testing is projected to grow significantly.Technology Trends:Molecular Diagnostics captured the largest share in 2025.Immunoassay technologies are expected to experience strong growth.Application Trends:Infectious Diseases dominated in 2025.Oncology is anticipated to show significant growth.End-User Trends:Standalone Laboratories held a major market share in 2025.Hospitals are expected to see considerable growth in adoption.In Vitro Diagnostics Market Revenue (USD Million), By Product Type, 2022 to 2024 Product202220232024Instruments28,950.526,909.5525,379.75Reagents75,883.970,996.2867,404.76Services10,654.39,861.369,264.58In Vitro Diagnostics Market Revenue (USD Million), By Technology, 2022 to 2024 Technology202220232024Immunoassay34,688.232,433.7230,774.22Hematology6,827.46,345.415,984.69Clinical Chemistry20,236.718,978.1418,061.02Molecular Diagnosis38,255.735,662.2633,736.25Coagulation4,680.54,328.274,061.72Microbiology6,384.95,916.295,563.15Others4,415.34,103.123,868.03In Vitro Diagnostics Market Revenue (USD Million), By Application, 2022 to 2024Application202220232024Infectious Diseases61,149.956,833.2753,602.44Diabetes9,146.68,475.367,969.48Oncology8,727.78,323.388,055.14Cardiology9,104.38,538.038,125.43Nephrology6,633.36,127.885,744.71Autoimmune Diseases5,350.64,987.834,718.45Drug Testing3,986.63,757.303,593.52Others11,389.610,724.1410,239.92✚ Note: This report is readily available for immediate delivery.Immediate Delivery Available | Buy This Premium Research Report@ https://www.precedenceresearch.com/checkout/1130What are In Vitro Diagnostics?In vitro diagnostics market growth is driven by the high prevalence of infectious diseases, the rise in age-related conditions, increasing awareness about preventive care, the development of point-of-care testing, increasing adoption of personalised medicine, and growing healthcare spending.In vitro diagnostics ...Full story available on Benzinga.com